Recommendation: Cardiovascular precision medicine – A pharmacogenomic perspective — R1/PR7

Опубликована: Июнь 9, 2023

Precision medicine envisages the integration of an individual's clinical and biological features obtained from laboratory tests, imaging, high-throughput omics health records, to drive a personalised approach diagnosis treatment with higher chance success. As only up half patients respond medication prescribed following current one-size-fits-all strategy, need for more is evident. One routes transforming healthcare through precision pharmacogenomics (PGx). Around 95% population estimated carry one or actionable pharmacogenetic variants over 75% adults 50 years old are on prescription known PGx association. Whilst there compelling examples pharmacogenomic implementation in practice, case cardiovascular still evolving. In this review, we shall summarise status diseases look at key enablers barriers practice.

Язык: Английский

Author comment: Cardiovascular precision medicine – A pharmacogenomic perspective — R0/PR1

Опубликована: Март 6, 2023

Precision medicine envisages the integration of an individual’s clinical and biological features obtained from laboratory tests, imaging, high-throughput omics health records, to drive a personalised approach diagnosis treatment with higher chance success. As only up half patients respond medication prescribed following current one-size-fits-all strategy, need for more is evident. One routes transforming healthcare through precision pharmacogenomics (PGx). Around 95% population estimated carry one or actionable pharmacogenetic variants over 75% adults 50 years old are on prescription known PGx association. Whilst there compelling examples pharmacogenomic implementation in practice, case cardiovascular still evolving. In this review, we shall summarise status diseases look at key enablers barriers practice.

Язык: Английский

Review: Cardiovascular precision medicine – A pharmacogenomic perspective — R1/PR6

Опубликована: Май 29, 2023

Precision medicine envisages the integration of an individual’s clinical and biological features obtained from laboratory tests, imaging, high-throughput omics health records, to drive a personalised approach diagnosis treatment with higher chance success. As only up half patients respond medication prescribed following current one-size-fits-all strategy, need for more is evident. One routes transforming healthcare through precision pharmacogenomics (PGx). Around 95% population estimated carry one or actionable pharmacogenetic variants over 75% adults 50 years old are on prescription known PGx association. Whilst there compelling examples pharmacogenomic implementation in practice, case cardiovascular still evolving. In this review, we shall summarise status diseases look at key enablers barriers practice.

Язык: Английский